Cocarnit (Dissodium adenosine triphosphate trihydrate & Cocarboxylase & Cyanocobalamin & Nicotinamide)
COMPOSITION
Each ampoule contains:
Dissodium adenosine triphosphate trihydrate 10 mg
Cocarboxylase 50 mg
Cyanocobalamin 0.5 mg
Nicotinamide 20 mg
THERAPEUTIC INDICATIONS
- Neuritis, neuropathy (in diabetes mellitus,
pernicious anemia and etc.);
- Neuralgia of various genesis;
- Myalgia, ischialgia;
- Lumbago, radiculitis;
- Bursitis, tendinitis;
- Ischemic cardiac disease, myocarditis, myocardiopathy.
CONTRAINDICATIONS
- Hypersensitivity to any of the drug component.
- Acute period of myocardial infarction.
- Hypersensitivity, hypercoagulation (including acute thrombosis), erythremia,
erythrocytosis, severe arterial hypertension, arterial hypotension, acute
myocardial infarction, inflammatory disease of lungs.
ADVERSE EFFECTS
Headache, vertigo, tachycardia, allergic
reactions (urticaria). IM injection may cause hyperemia, pruritus and edema in
the site of introduction. The drug is discontinued when apparent adverse effects
appear.
DOSAGE AND ADMINISTRATION
1-2 ampoules of Cocarnit are IM injected once
daily.
The duration of therapy and initiation of refresher course of treatment depends
on kind and severity of disease.
DRUG INTERACTIONS
Cocarboxylase enhances a cardiotonic action of
cardiac glycosides.
PREGNANCY AND LACTATION
Cocarnit should be applied during pregnancy only
if expected benefit for mother justifies potential risk for fetus.
Breast-feeding should be discontinued during drug therapy.
MANUFACTURED FORM
Lyophilized powder for injections in glass
ampoules. 3 ampoules complete with a solvent (3 (2 ml) ampoules of 0.5%
lidocaine hydrochloride) are in strips in a carton box with an
annotation-insert.
|